Search Results - "Emelyanova, G. S."
-
1
Potential for use sunitinib in pancreatic neuroendocrine tumors
Published in Medicinskij sovet (24-06-2019)“…The treatment efficacy and toxicity profile was evaluated in 33 patients with highly differentiated neuroendocrine tumors NEO (G1, G2), who received sunitinib…”
Get full text
Journal Article -
2
Sunitinib in pancreatic neuroendocrine tumors. Clinical case
Published in Medicinskij sovet (09-12-2019)“…The article describes a rare clinical case. Progression of the disease in the form of multiple metastases to the liver, lymph nodes of the hepatoduodenal…”
Get full text
Journal Article -
3
THE USE OF SORAFENIB (NEXAVAR) IN TREATMENT OF PATIENT WITH DISSEMINATED PARATHYROID CANCER: A CASE REPORT
Published in Opukholi golovy i shei (01-04-2017)“…Parathyroid carcinoma (PC) is a rare neoplasm with a prevalence of only 0.005 % of all malignancies, and less than 1 % among patients with primary…”
Get full text
Journal Article -
4
Experience of use of everolimus and long-acting somatostatin analogues combination in highly differentiated (G1-G2) neuroendocrine tumors
Published in Sovremennaia onkologiia : zhurnal kafedry onkologii RMAPO dlia nepreryvnogo poslediplomnogo obrazovaniia (01-09-2015)“…Everolimus is the targeted drug approved for the treatment of neuroendocrine tumors (NET). Efficacy of everolimus in combination with octreotide-depo has been…”
Get full text
Journal Article -
5
Lanreotide for the treatment of patients with disseminated high-grade neuroendocrine tumors: the experience of application in case of unsatisfactory tolerability of octreotide
Published in Sovremennaia onkologiia : zhurnal kafedry onkologii RMAPO dlia nepreryvnogo poslediplomnogo obrazovaniia (01-03-2016)“…Somatostatin analogs plays a key role in the treatment of disseminated well-differentiated functioning and nonfunctioning neuroendocrine tumors (NET). Its…”
Get full text
Journal Article